Sort
261,768 grants matching “gene therapy”
Modulating Cancer Stem Cell Signaling in Thoracic Malignancies
$896,491David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Overcoming pre-existing immunity to AAV to enhance AAV-based HIV immunotherapies
$896,461Mauricio De Aguiar Martins · University Of Florida · R01 · FY2023 · AI
Mediators of cancer cell homeostasis: intervention targets common to diverse types of cancer
$896,385Hartmut Land · University Of Rochester · R35 · FY2017 · CA
Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations
$896,349Vittorio Porciatti · University Of Miami School Of Medicine · R24 · FY2020 · EY
SPORE in Breast Cancer
$896,275Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2024 · CA
SPORE in Bladder Cancer
$896,275Jonathan Eric Rosenberg · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
NYU Melanoma SPORE
$896,274Iman Osman · New York University School Of Medicine · P50 · FY2024 · CA
Administrative Supplement: Interim Funding for Emory Lung Cancer SPORE
$896,274Suresh S Ramalingam · Emory University · P50 · FY2024 · CA
The Genetic Basis of Conotruncal Defects
$896,226Elizabeth Goldmuntz · Children'S Hosp Of Philadelphia · U01 · FY2012 · HL
Molecular Therapy Core Centers
$896,208Arthur Dusty Miller · University Of Washington · P30 · FY2006 · DK
ECOG Specimen Banking
$896,177Robert L Comis · Frontier Sci & Technology Rsch Fdn, Inc · U24 · FY2011 · CA
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV
$896,116Ronald J. Ellis · University Of California, San Diego · R01 · FY2022 · DA
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV
$896,116Ronald J. Ellis · University Of California, San Diego · R01 · FY2023 · DA
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV
$896,116Ronald J. Ellis · University Of California, San Diego · R01 · FY2025 · DA
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV
$896,116Ronald J. Ellis · University Of California, San Diego · R01 · FY2024 · DA
Preventing Anthracycline Cardiovascular Toxicity with Statins
$896,071William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2017 · HL
Non-invasive Electrical Stimulation as a Therapy for Diabetic Keratopathy
$896,046Menglu Yang · Schepens Eye Research Institute · R56 · FY2025 · EY
Enhancing Native American Participation in RT Trials
$896,038Rapid City Regional Hospital · U56 · FY2003 · CA
Amelioration of Vesicant-Induced Skin Injury by High Dose 25-Hydroxyvitamin D
$896,035Kurt Lu · Case Western Reserve University · U01 · FY2016 · AR
Inhibitors of poxvirus enzymes as novel drugs
$896,022Esteban Edward Mena · Lifepharms, Inc. · U01 · FY2009 · AI
Immune selection of HIV-1 reservoir cells in human clinical trials
$895,990Mathias Lichterfeld · Brigham And Women'S Hospital · R01 · FY2024 · AI
Translational Training Grant in Experimental Therapeutics
$895,907John C Byrd · Ohio State University · K12 · FY2009 · CA
Therapeutic Targeting of Human AML Stem Cells
$895,854Craig T. Jordan · University Of Colorado Denver · R35 · FY2023 · CA
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$895,829Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Emerging Strategies for Therapy of Metastatic Brain Cancer
$895,779Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2024 · CA